Oxbryta Lawsuit

Oxbryta Lawsuit: Seeking Justice for Sickle Cell Patients

Pfizer recently announced a global recall of Oxbryta, a medication developed to manage symptoms of sickle cell disease (SCD). Alarmingly, new studies indicate that instead of providing relief, Oxbryta may increase the risk of severe complications, including vaso-occlusive crises (VOCs) and even fatalities. Shamis Gentile is currently representing affected patients in legal action against Pfizer.

If you or a loved one took Oxbryta and experienced worsening symptoms or serious side effects, you may be entitled to compensation. Our attorneys are committed to holding Pfizer accountable and fighting for the recovery you deserve.

What is Oxbryta?

Oxbryta (voxelotor) was introduced as an innovative treatment for sickle cell disease, aimed at improving hemoglobin’s ability to bind oxygen and reducing red blood cell sickling. Approved by the FDA in 2019, the drug was initially seen as a significant advancement for individuals living with SCD. However, subsequent studies revealed that the risks of Oxbryta often outweigh its benefits.

Patients taking Oxbryta reported a higher incidence of severe complications, such as VOCs, which can lead to life-threatening outcomes. Sickle cell patients placed their trust in Oxbryta to manage their condition, yet Pfizer’s failure to fully disclose its risks has caused unnecessary suffering. Shamis Gentile is dedicated to helping victims seek justice and obtain fair compensation for their hardships.

Health Risks Associated with Oxbryta

• Vaso-Occlusive Crises (VOCs): Oxbryta has been linked to an increased risk of VOCs, a painful and dangerous complication of sickle cell disease. These occur when sickled red blood cells block blood flow to tissues, leading to intense pain, organ damage, and long-term health issues such as kidney failure or stroke. Patients on Oxbryta experienced VOCs more frequently than those not using the drug.
• Fatal Complications: Alarmingly, studies have shown a higher rate of deaths among Oxbryta users compared to placebo groups, raising serious concerns about Pfizer’s safety protocols and transparency regarding the drug’s risks.

How We Can Help

Shamis Gentile PA is leading legal efforts against Pfizer, representing individuals harmed by Oxbryta’s side effects. We believe Pfizer did not adequately test Oxbryta or disclose the significant risks it posed to vulnerable SCD patients. Our legal team is working tirelessly to hold Pfizer accountable and secure compensation for those affected.
Victims of Oxbryta may qualify for compensation covering:

• Medical Costs: Including hospital visits, treatments, and ongoing care for VOCs or other complications.
• Lost Wages: Reimbursement for missed work due to illness or treatment.
• Pain and Suffering: Compensation for the physical and emotional challenges caused by Oxbryta-related complications.
• Punitive Damages: In cases where Pfizer’s actions are deemed particularly negligent, courts may award punitive damages to penalize the company.

Take Action Today

If you or someone you know suffered due to Oxbryta, don’t delay. Contact us for a free consultation and let us help you seek justice. Time is critical for filing a claim, so act now to protect your rights. You may be entitled to significant compensation.

File a claim today